The immunogenicity of human and murine cytomegaloviruses.
about
Cell-mediated immunity to human CMV infection: a brief overviewAntigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challengeLong-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons.Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungsExperimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner.Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γAge-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replicationTwo antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: an unpredicted novel function of cytomegalovirusProcessing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functionsDevelopment of a cytomegalovirus vaccine: lessons from recent clinical trials.Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.Mature CD8(+) T lymphocyte response to viral infection during fetal lifeCross-reactivity of HLA-B*1801-restricted T-lymphocyte clones with target cells expressing variants of the human cytomegalovirus 72kDa-IE1 protein.SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replicationLymph Node Macrophages Restrict Murine Cytomegalovirus DisseminationDNA immunization using highly conserved murine cytomegalovirus genes encoding homologs of human cytomegalovirus UL54 (DNA polymerase) and UL105 (helicase) elicits strong CD8 T-cell responses and is protective against systemic challenge.AIDS-related cytomegalovirus retinitis: lessons from the laboratory.HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytesMHC immunoevasins: protecting the pathogen reservoir in infection.T cells and viral persistence: lessons from diverse infections.Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cellsA cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction.Age-related appearance of a CMV-specific high-avidity CD8+ T cell clonotype which does not occur in young adults.A bipartite trigger for dislocation directs the proteasomal degradation of an endoplasmic reticulum membrane glycoproteinVaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humansAgeing and life-long maintenance of T-cell subsets in the face of latent persistent infectionsDeveloping a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cellsCXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10.Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals.Lytic viral replication and immunopathology in a cytomegalovirus-induced mouse model of secondary hemophagocytic lymphohistiocytosis.The convergent epidemiology of tuberculosis and human cytomegalovirus infection.
P2860
Q27026981-3C457A53-84D7-4856-8124-4E80CD67EE63Q27632371-357D234F-C2C7-4C94-9433-DAD81EFCDF29Q30491742-6784C55F-370B-42D4-A577-B76E6ECDF038Q33551402-C2771945-34C5-47C9-BAEB-D0289EE65141Q33737729-214D1590-D290-4FBA-8F64-D5C8E33065ABQ33812288-B14E99D4-E5F0-4F4A-B730-C6E4120233FEQ33843590-9D5DF54D-93C8-4271-B224-008C8B0CB9C6Q33851857-BB254CDB-4DC0-4F77-AE4D-5E61DB676345Q33865510-F079AB88-39EF-4E21-989E-BD24FEC1FD29Q33886711-197FCDFA-A3AC-4F34-8DAE-5C196FF71235Q34165203-A51EBC0B-495E-4334-9D18-010CEBA23CD6Q34327234-6F388CFF-287A-4A45-8038-C170089CF57BQ34333053-E77ABEB3-DAC6-49F5-B270-32C7AC8CA360Q34339686-CC962A6E-DAAF-4730-8603-CF66951441FDQ34451960-A3018575-9C9D-47FD-AC8B-F080BF35C538Q34975513-11D87CE1-B674-4DB4-BE67-7C65EED76BACQ35019349-06DBE244-7D13-4A50-B4CE-91F4995925E8Q35020384-E23FAA16-465F-4AF0-B368-52AE6E1A38F0Q35123249-AB24C63E-93C8-4F1D-B8CC-00656508CDDFQ35758610-EA43E752-498E-4645-AF64-A3AB28996049Q35914513-15BCC32C-4995-402F-894E-0FE5A646BEBEQ35932191-42A9D507-E4E7-41E6-AD04-F2F1643005D6Q35978622-1E2A8C57-DC37-4194-BAAE-792957A472ABQ36176408-1C0EC4B7-001A-4622-87EA-4F9D5723BFF0Q36238129-9102E808-DEED-4959-8985-F6C62E1F8CDDQ36370707-D07F4248-0609-495D-9E0D-294C73EFBE97Q36403003-D99A9B4F-1387-469C-837C-7C2BE649F14FQ36960167-1D2AF34F-3CFA-4CF7-A63E-B7C81BAD2DE4Q36999534-81E1873B-8219-4E76-9772-BA32E3FAF50CQ37034786-445A3B0D-6C54-4A69-8821-4C6DA6E788A6Q37089515-D8D4F61A-77C3-4934-983D-6EE4F70060E1Q37159086-54A2EDA3-CADB-4FC8-9439-E5AF592618C1Q37574334-A9DE8C69-103F-4BB2-802C-3BAF98CC5B39Q38042835-8168C958-B4B2-4262-BD85-8E9CE505BFF9Q39681740-B788F229-FB75-4A49-AEFC-247B245C0952Q39742087-AB2B2E62-E899-4256-BD7B-17882AF8C501Q39960613-2B221B2A-2EE8-4878-A3E6-69E252B60B0CQ46678222-48007D1F-FF8C-4763-902F-2295384221F4Q47192748-3577F9B4-FE07-4AF0-A287-D346AF6AA3C6Q54202530-B810B6DF-1A32-4E7E-8525-F8815D817F46
P2860
The immunogenicity of human and murine cytomegaloviruses.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The immunogenicity of human and murine cytomegaloviruses.
@ast
The immunogenicity of human and murine cytomegaloviruses.
@en
type
label
The immunogenicity of human and murine cytomegaloviruses.
@ast
The immunogenicity of human and murine cytomegaloviruses.
@en
prefLabel
The immunogenicity of human and murine cytomegaloviruses.
@ast
The immunogenicity of human and murine cytomegaloviruses.
@en
P1476
The immunogenicity of human and murine cytomegaloviruses.
@en
P2093
Reddehase MJ
P304
P356
10.1016/S0952-7915(00)00106-0
P577
2000-08-01T00:00:00Z